Chemotherapy for Prostate Cancer: a Shared Decision

This podcast is sponsored by Sanofi. Participants have been compensated and/or received an honorarium from Sanofi in connection with this podcast. This content was jointly developed by the participants and Sanofi. This is a promotional event and no CME credits are offered.

Healthcare providers face a communication challenge when it comes to talking about chemotherapy with their patients who have prostate cancer. This podcast, geared toward oncologists, primary physicians, and nurse practitioners, explores some of the myths and misconceptions men and their caregivers may have about chemotherapy as a treatment option for prostate cancer. Our experts provide tips for how to talk with patients about their fears, and they offer information to encourage shared decision making so that patients understand whether chemotherapy may be the right choice for prostate cancer.

Host
Pedro Barata, MD, MSc, associate professor and medical oncologist, Tulane Comprehensive Cancer Center

Guests
Rana McKay, MD, associate professor and medical oncologist, UC San Diego Health

Vivek Narayan, MD, MS, assistant professor of medicine, University of Pennsylvania; medical oncologist, Hospital of the University of Pennsylvania

©2023 sanofi-aventis U.S. LLC - All rights reserved.
MAT-US-2302472-v1.0-04/2023

Host

Dr. Pedro Barata

Dr Pedro Barata is associate professor at Tulane Medical School and is a genitourinary medical oncologist at Tulane Comprehensive Cancer Center. His areas of specialty include prostate, kidney, and bladder cancers. Dr Barata has authored and coauthored scores of research publications and textbook chapters and is a reviewer and editor for several peer-reviewed oncology publications, including The Oncologist, Clinical Genitourinary Cancer journal, and Translational Oncology journal. He has presented at numerous national and international meetings.